Leaders Discuss Best Practices, Challenges For Detecting Counterfeit Medications

Main Category: Pharma Industry / Biotech Industry
Article Date: 05 Nov 2010 - 5:00 PDT

Current ratings for:
'Leaders Discuss Best Practices, Challenges For Detecting Counterfeit Medications'

Patient / Public:not yet rated

Healthcare Prof:not yet rated

During the opening of the 10th annual meeting of the International Society of Pharmacovigilance (ISoP) in Accra, Ghana, the country's "Vice President John Dramani Mahama on Wednesday called on member countries of [the society] to institute effective measures that would help detect fake and counterfeit drugs," Ghana News Agency reports.

The ISoP, which includes members from across the world, "is an international non-profit scientific organisation, which aims at fostering pharmacovigilance both scientifically and educationally, and to enhance all aspects of the safe and proper use of medicines in all countries," according to the news service.

During his speech, Mahama said foreign aid provided "to developing countries to fight diseases would not benefit them if vigilance is not intensified to eliminate the malpractices in drug administration." He also "called on member countries to tighten their security networks to ensure that proper drug administration is practised to repose more confidence in the existing pharmaceutical companies," Ghana News Agency writes.

The "government of Ghana is creating the necessary environment to become a global major actor in the vigilance against counterfeiting and misuse of drugs and I will like to call on all of you here to do same in your countries," Mahama said to attendees. The article also includes comments by ISoP President Alexander Doodoo, and Serge Xueref, an official with the Global Fund to Fight AIDS, Tuberculosis and Malaria (11/3).

The ISoP meeting followed the 33rd Annual Meeting of Representatives of the National Centres participating in the WHO Programme for International Drug Monitoring, that was also held in Accra, according to an agenda (.pdf) released by the WHO (undated).

"This is the first time that major global drug safety events are being held in sub-Saharan Africa and the choice of Ghana reflects the increasing stature attained by the country in Global Drug Safety," Ghana News Agency reports in a separate article. According to the news service, "[m]ore than 500 participants representing pharmacovigilance professionals from across the globe" were to attend the ISoP meeting to "examine pharmacovigilance practices across the globe with a view to sharing best practices, highlighting common challenges and developing broad principles for dealing with them."

The article includes quotes made ahead of the meeting by Doodoo and ISoP's Brian Edwards and Delese Mimi Darko(10/25).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Leaders Discuss Best Practices, Challenges For Detecting Counterfeit Medications." Medical News Today. MediLexicon, Intl., 5 Nov. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/206823.php>
APA
Kaiser. (2010, November 5). "Leaders Discuss Best Practices, Challenges For Detecting Counterfeit Medications." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/206823.php.

Please note: If no author information is provided, the source is cited instead.


Add Your Opinion On This Article

'Leaders Discuss Best Practices, Challenges For Detecting Counterfeit Medications'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »